Chemical and biological evaluation of scandium(III)- polyaminopolycarboxylate complexes as potential PET agents and radiopharmaceuticals

Radiochimica Acta

Volumn 99, Issue 10, 2011, Pages 653-662

  Huclier Markai, S ^a   Sabatie, A ^a   Ribet, S ^a   Kubicek V ^b   Paris, M ^a   Vidaud, C ^c   Hermann, P ^b   Cutler, C S ^d  

^a UNIVERSITÉ DE NANTES   (France)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CEA/DSV   (France)

^d UNIVERSITY OF MISSOURI   (United States)

Author keywords

Polyaminopolycarboxylate ligands; Positron emission tomography; Scandium complexes; Stability

Indexed keywords

EID: 80053200419     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2011.1869     Document Type: Article

References (48)

1. Mausner, L. F., Kolsky, K. L., Joshi, V., Srivastava, S. C: Radionuclide development at BNL for nuclear medicine therapy. Appl. Radiat. Isot. 49, 285 (1998).
2. Mausner, L. F., Joshi, V., Kolsky, K. L., Meinken, G. E., Mease, R. C., Sweet, M. P., Srivastava, S. C: Evaluation of chelating agents for radioimmunotherapy with scandium-47. J. Nucl. Med. 36, 104 (1995).
3. Kolsky, K. L., Pietrelli, L., Mausner, L. F., Srivastava, S. C: Radiochemical purification of no-carrier-added scandium-47 for radioimmunotherapy. J. Nucl. Med. 32, 945 (1995).
4. 44Sc radionuclide with liquid xenon as detection medium. Nucl. Instrum. Methods Phys. Res. A 571(1-2), 142 (2007).
5. Anderegg, G., Arnaud-Neu, F., Delgado, R., Felcman, J., Popov, K: Critical evaluation of stability constants of metal complexes of complexones for biomedical and environmental applications. Pure Appl. Chem. 77(8), 1445 (2005).
6. 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours. Eur. J. Nucl. Med. Mol. Imag. 33(5), 532 (2006).
7. Urbano, N., Papi, S., Ginanneschi, M., De Santis, R., Pace, S., Lindstedt, R., Ferrari, L., Choi, S., Paganelli, G., Chinol, M.: Evaluation of a new biotin-DOTA conjugate for pretargeted antibodyguided radioimmunotherapy (PAGRIT). Eur. J. Nucl. Med. Mol. Imag. 34(1), 68 (2007).
8. Loncin, M. F., Desreux, J. F., Merciny, E.: Coordination of lanthanides by two polyamino polycarboxylic macrocycles: formation of highly stable lanthanide complexes. Inorg. Chem. 25, 2646 (1986).
9. Moi, M. K., Meares, C. F., DeNardo, S. J.: The peptide way of macrocyclic bifunctional chelating agents. Synthesis of 2-(pnitrobenzyl)-1, 4, 7, 10-tetracyclododecane-N, N', N", N'", N""-tetraacetic acid, and study of its yttrium (III) complex. J. Am. Chem. Soc. 110, 6266 (1988).
10. Izatt, R., Pawlak, K., Bradshaw, S. J., Bruening, R. L.: Thermodynamic and kinetic data for macrocycle interaction with cations, anions, and neutral molecules. Chem. Rev. 95, 2529 (1995).
11. Bianchi, E., Denti, S., Granata, A., Bossi, G., Geginat, J., Villa, A., Rogge, L., Pardi, R.: Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature 404(6778), 617 (2000).
12. Cacheris, W. P., Quay, S. C., Rocklage, S. M.: The relationship between thermodynamics and the toxicity of gadolinium complexes. Mag. Res. Imag. 8, 467 (1990).
13. Itoh, H., Itoh, N., Suzuki, Y: Stability constants of scandium complexes II. dicarboxylate complexes species. Bull. Chem. Soc. Jpn. 57(3), 716 (1984).
14. Itoh, H., Ikegami, Y., Suzuki, Y: Stability constants of scandium complexes. I. Monocarboxylate complexes Species. Bull. Chem. Soc. Jpn. 57(12), 3426 (1984).
15. Bottari, E.: Anderegg, Complexons. XLII. Study of 1: 1 complexes of some tri-and tetravalent metal ions with polyaminocarboxylates by redox measurement. Helv. Chim. Acta 50, 2349 (1967).
16. Byegard, J., Skarnemark, G., Skalberg, M.: The stability of some metal EDTA, DTPA and DOTA complexes: applications as tracers in groundwater studies. J. Radioanal. Nucl. Chem. 241(2), 281 (1999).
17. 177Lu with zoledronic acid for bone pain therapy. Appl. Radiat. Isot. 67(1), 11 (2009).
18. Majkowska-Pilip, A., Bilewicz, A.: Macrocyclic complexes of scandium radionuclides as precursors for diagnostic and therapeutic radiopharmaceuticals. J. Inorg. Biochem. 105, 313-320 (2011).
19. Otte, A., Jermann, E., Behe, M., Goetze, M., Buchet, H. C., Roser, H. W., Heppeler, A., Mueller-Brand, J., Macke, H. R.: DOTATOC: a powerful new tool for receptor mediated radionuclide therapy. J. Nucl. Med. 24, 792 (1997).
20. 90Y]-Bz-DTPA octreotide: a yttrium 90-labelled octreotide analogue for radiotherapy of stomatostatin receptor-positive tumors. Nucl. Med. Biol. 25, 181 (1998).
21. Li, W. P., Ma, D. S., Higginbotham, C., Hoffman, T., Ketring, A. R., Cutler, C. S., Jurisson, S. S.: Development of an in vitro model for assessing the in vivo stability of lanthanide chelates. Nucl. Med. Biol. 28, 145 (2001).
22. Jurkin, D., Gildehaus, F. J., Wierczinski, B.: Kinetic stability studies of yttrium (III)-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid by free ion selective radiotracer extraction. Anal. Chem. 79, 9420 (2007).
23. Jurkin, D., Wierczinski, B.: Analysis of the kinetic stability of yttrium (III)-chelates by free ion selective radiotracer extraction (FISRE). J. Radioanal. Nucl. Chem. 277(1), 91 (2008).
24. Jurkin, D., Gildehaus, F. J., Wierczinski, B.: Dissociation kinetic determination of yttrium (III)-polyaminopolycarboxylates using free ion selective radiotracer extraction (FISRE). J. Labelled Compd. Radiopharm. 52, 33 (2009).
25. Desreux, J. F.: Nuclear magnetic resonance spectroscopy of lanthanide complexes with a tetraacetic tetraaza macrocycle. Unusual conformation properties. Inorg. Chem. 19, 1319 (1980).
26. 2+ to apotransferrin: can this protein account for entry into human cells? Biochemistry 46, 2215 (2007).
27. 5do3ap and similar DOTA-like ligands. J. Fluorescence 15(4), 507 (2005).
28. Martell, A. E., Smith, R. M.: Critical Stability Constants. Vols. 1-6, Plenum Press, New York (1974-1989).
29. Van der Lee, J., De Windt, L.: Present state and future directions of modeling of geochemistry in hydrogeological systems. J. Contam. Hydrol. 47, 265 (2001).
30. Kulprathipanja, S., Hnatowithch, D. J., Beh, R., Elmaleh, D.: Formation constants of gallium and indium-transferrin. Int. J. Nucl. Med. Biol. 6(2), 138 (1979).
31. Cole, W. C., Denardo, S. J., Meares, C. F., McCall, M. J., Denardo, G. L, Epstein, A. L., Obrien, H. A., Moi, M. K: Comparative serum stability of radiochelates for antibody radiopharmaceuticals. J. Nucl. Med. 28(1), 83 (1987).
32. Ford-Hutchinson, A. W., Perkins, D. J.: The binding of scandium ions to transferrin in vivo and in vitro. Eur. J. Biochem. 21(1), 55 (1971).
33. Aime, S., Geninatti-Crich, S., Gianolio, E., Giovenzana, G. B., Tei, L., Terreno, E.: High sensitivity lanthanides (III) based probes for MR-medical imaging. Coord. Chem. Rev. 250, 1562 (2006).
34. Corneillie, T. M., Whetstone, P. A., Fisher, A. J., Meares, C. F.: A rare earth-DOTA-binding antibody: probe properties and binding affinity across the lanthanide series. J. Am. Chem. Soc. 125(12), 3436 (2003).
35. Shubert, J.: The use of ion exchangers for the determination of physical-chemical properties of substances, particularly radiotracers in solutions. J. Phys. Chem. 62, 340 (1948).
36. Shubert, J.: Analytical applications of ion exchange separations. 3rd Annual Summer Symposium - Separations. Anal. Chem. 22(11), 1360 (1950).
37. Shubert, J., Lind, E. L., Westfall, W. M., Plefger, R., Li, N. C: Ionexchange and solvent-extraction studies on Co (II) and Zn (II) complexes of some organic acids. J. Phys. Chem. 80, 4799 (1958).
38. 3+ with 1, 4, 7, 10-tetrakis (carboxymethyl) - 1, 4, 7, 10-tetraazacyclododecane (dota) - characterization of three successive complexing phases: study of the thermodynamic and structural properties of the complexes by potentiometry, luminescence spectroscopy, and EXAFS. Chem. Eur. J. 10, 5218 (2004).
39. Delgado, R., Costa, J., Guerra, K. P., Lima, L. M. P.: Lanthanides complexes of macrocyclic derivatives useful for medical applications. Pure Appl. Chem. 77(3), 569 (2005).
40. Woods, M., Kovács, Z., Kiraly, R., Brucher, E., Zhang, S., Sherry, A. D.: Solution dynamics and stability of lanthanides (III) (S) - 2-(p-nitrobenzyl) DOTA complexes. Inorg. Chem. 43(9), 2845 (2004).
41. Port, M., Idee, J.-M., Medina, C., Robic, C., Sabatou, M., Corot, C: Biometals 21, 469-490 (2008).
42. Shannon, R. D.: Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides. Acta Crystallogr. A 32, 751 (1976).
43. Meehan, P. R., Aris, D. R., Willey, G. R.: Structural chemistry of Sc (III): an overview. Coord. Chem. Rev. 181, 121 (1999).
44. Li, W. P., Meyer, L. A., Anderson, C. J.: Radiopharmaceuticals for positron emission tomography imaging for somatostatin receptor positive tumors. Top. Curr. Chem. 252, 179 (2005).
45. Bass, L. A., Wang, M., Welch, M. J., Anderson, C. J.: In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjugate Chem. 11, 527 (2000).
46. Anderson, W. T., Strand, M.: Stability, targeting and biodistribution of scandium-46 and gallium-67-labeled monoclonal antibody in erythroleukemic mice. Cancer Res. 45, 2154 (1985).
47. Wu, A. M., Yazaki, P. J., Tsai, S. W., Nguyen, K., Anderson, A. L., McCarthy, D. W., Welch, M. J., Shively, J. E., Williams, L. E., Raubitschek, A. A., Wong, J. Y., Toyokuni, T., Phelps, M. E., Gambhir, S. S.: High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc. Natl. Acad. Sci. USA 97, 8495 (2000).
48. 90Y-DOTATOC. J. Nucl. Med. 43, 610 (2002).